Skip to content

To assess the effect of dried powder of flower buds of Hibiscus rosa-sinensis Linn in Excessive menstrual bleeding conditions in women .

Effect of Bhavitha choorna of Japakusuma mukula (flower buds of Hibiscus rosa-sinensis Linn) with Ksheera in Asrigdhara.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044981
Enrollment
30
Registered
2022-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Sponsors

Goverment Ayurveda College Tripunithura
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18-50 years. 2. Excessive bleeding during menstruation (change of more than 3 soiled pads per day). 3. Prolonged menstrual bleeding. 4. Passing of large clots. 5. Cycle intervals less than 21 days.

Exclusion criteria

Exclusion criteria: 1. Patients with known cases of organic pelvic pathology of uterus such as fibroid uterus, ovarian cyst, PID, myomas, endometrial polyp, endometriosis. 2. Hb less than 8 %. 3. Conditions of pregnancy and abortion. 4. Women using an IUCD /OCP. 5. Patients having bleeding from other sites. 6. Patients with known cases of chronic systemic diseases like a) Severe hypertension b) Liver dysfunction c) Coagulation disorder d) Tuberculosis e) Venereal diseases f) Endometrial or cervical carcinoma

Design outcomes

Primary

MeasureTime frame
The patients were assessed based on PBAC Scoring criteria, • Bleeding amount • Size of clots • Duration of bleeding • Interval of menstruation • Pain in abdomen /low back • FatigueTimepoint: Patients will be assessed before, during and after treatment. Assessment will be done using PBAC Scale (Pictorial blood assessment chart) before treatment (symptoms experienced during menstruation prior to treatment) and at every 5 days from the onset of menstrual bleeding during 3 consecutive cycles of treatment and next 3 consecutive cycles of follow up based on patient’s statement.

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactSHINCYMOL VV

Government Ayurveda College Tripunithura , Ernakulam

shincymol@ayurvedacollege.ac.in9947012863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026